Literature DB >> 1635120

Home screening for hematuria: results of a multiclinic study.

E M Messing1, T B Young, V B Hunt, E B Roecker, A M Vaillancourt, W J Hisgen, E B Greenberg, M E Kuglitsch, J D Wegenke.   

Abstract

The majority of urinary tract tumors cause bleeding in the urine. A program designed to detect hematuria before it is grossly apparent may contribute to earlier detection and more successful treatment of these malignancies. To test this hypothesis a hematuria home screening study was conducted. A total of 1,340 healthy men 50 years old or older used chemical reagent strips for 14 consecutive days to test the urine. Of the men 283 (21.1%) had at least 1 episode of hematuria. Of the 192 hematuria positive men who received a complete urological evaluation 16 (8.3%) had urological cancers and 47 (24.5%) had other hematuria-causing diseases that required immediate treatment. The quantity and frequency of hematuria were not related to disease severity. A hematuria home screening regimen is feasible and economical, and may promote the early detection of urinary tract cancers and other diseases in men more than 50 years old.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1635120     DOI: 10.1016/s0022-5347(17)36575-8

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  19 in total

1.  [Molecular markers in the diagnostics and therapy of urothelial cancer].

Authors:  C Protzel; O W Hakenberg
Journal:  Urologe A       Date:  2010-11       Impact factor: 0.639

2.  Glomerular isolated microscopic hematuria: urinary features and long term follow-up of a selected cohort of patients.

Authors:  Cecilia Bellincioni; Giuseppe Garigali; Giovanni B Fogazzi
Journal:  J Nephrol       Date:  2018-12-10       Impact factor: 3.902

Review 3.  Cystoscopy in the evaluation of benign prostatic hyperplasia.

Authors:  F A Madsen; R C Bruskewitz
Journal:  World J Urol       Date:  1995       Impact factor: 4.226

4.  The prevalence of microscopic hematuria in a cohort of women with pelvic organ prolapse.

Authors:  Nirmala Pillalamarri; Dara Shalom; Sharlene Sanidad; Meredith Akerman; Lawrence Lind; Harvey Winkler
Journal:  Int Urogynecol J       Date:  2014-07-01       Impact factor: 2.894

5.  Japanese guidelines of the management of hematuria 2013.

Authors:  Shigeo Horie; Shuichi Ito; Hirokazu Okada; Haruhito Kikuchi; Ichiei Narita; Tsutomu Nishiyama; Tomonori Hasegawa; Hiroshi Mikami; Kunihiro Yamagata; Tomoji Yuno; Satoru Muto
Journal:  Clin Exp Nephrol       Date:  2014-10       Impact factor: 2.801

6.  Urine cytology and adjunct markers for detection and surveillance of bladder cancer.

Authors:  Peggy S Sullivan; Jessica B Chan; Mary R Levin; Jianyu Rao
Journal:  Am J Transl Res       Date:  2010-07-25       Impact factor: 4.060

7.  Recommendations for the improvement of bladder cancer quality of care in Canada: A consensus document reviewed and endorsed by Bladder Cancer Canada (BCC), Canadian Urologic Oncology Group (CUOG), and Canadian Urological Association (CUA), December 2015.

Authors:  Wassim Kassouf; Armen Aprikian; Peter Black; Girish Kulkarni; Jonathan Izawa; Libni Eapen; Adrian Fairey; Alan So; Scott North; Ricardo Rendon; Srikala S Sridhar; Tarik Alam; Fadi Brimo; Normand Blais; Chris Booth; Joseph Chin; Peter Chung; Darrel Drachenberg; Yves Fradet; Michael Jewett; Ron Moore; Chris Morash; Bobby Shayegan; Geoffrey Gotto; Neil Fleshner; Fred Saad; D Robert Siemens
Journal:  Can Urol Assoc J       Date:  2016-02-08       Impact factor: 1.862

Review 8.  Molecular screening for bladder cancer: progress and potential.

Authors:  Anirban P Mitra; Richard J Cote
Journal:  Nat Rev Urol       Date:  2010-01       Impact factor: 14.432

9.  Incidence of isolated dipstick hematuria and its association with the glomerular filtration rate: a cross-sectional study from the Korean National Health and Nutrition Examination Survey V (2010-2012).

Authors:  Hanna Kwon; Dong-Gi Lee; Hee Cheol Kang; Jun Ho Lee
Journal:  Int Urol Nephrol       Date:  2016-01-25       Impact factor: 2.370

10.  Predicting risk of bladder cancer using clinical and demographic information from prostate, lung, colorectal, and ovarian cancer screening trial participants.

Authors:  Maria C Mir; Andrew J Stephenson; Robert L Grubb; Amanda Black; Adam S Kibel; Grant Izmirlian
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-10-02       Impact factor: 4.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.